Location via proxy:   [ UP ]  
[Report a bug]   [Manage cookies]                
STAT

STAT+: Pharmalittle: We’re reading about a Merck pneumococcal shot, Kansas suing Pfizer, and more

In today's Pharmalittle roundup, we're reading about a Merck pneumococcal shot, Kansas suing Pfizer, and more.
Source: Alex Hogan/STAT

Top of the morning to you, and a fine one it is. Clear blue skies and comfortable breezes are enveloping the Pharmalot campus, although we expect the steam to rise any moment now. As

You’re reading a preview, subscribe to read more.

More from STAT

STAT2 min read
STAT+: Pharmalittle: We’re Reading About A CVS Deal With Illinois, A Pfizer Hemophilia Therapy, And More
CVS Caremark, one of the largest PBMs, agreed to pay at least $45 million to the state of Illinois to settle allegations that rebates were not passed through.
STAT1 min readChemistry
STAT+: The Race To Build Better CRISPR Delivery Vehicles Is Heating Up
Turning powerful gene-editing technologies into broadly useful therapies will require delivery vehicles at once more simple and far more complicated.
STAT1 min read
Opinion: Give Pharmaceutical Execs The Benefit Of Doubt — But They Need To Work For It
Pharma leaders have dual missions: advancing health and being responsible to shareholders. They must be held accountable for executing effective strategies for both.

Related Books & Audiobooks